NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Simsen Diagnostics

Simsen Diagnostics

Private
MölndalHealthcare & Life Scienceshttps://simsendiagnostics.com/

Last Round

Early Funding

May 5, 2026

Total Funding Raised

$1.41M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Simsen Diagnostics is a healthcare technology company that specializes in ultra-sensitive, personalized blood tests that detect and monitor cancer by analyzing circulating tumor DNA (ctDNA).

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

liquid biopsycancer monitoringmolecular residual diseaseMRDcirculating tumor DNActDNAprecision medicinetumour-informed biopsypatient-specific testultrasensitive sequencingclinical trial servicesoncology diagnosticscancer diagnosticsin-house lab solutionbioinformaticsdiagnostic reagents

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Simsen Diagnostics Comps

Public and private peers based on sector, stage, and business model.

Simsen Diagnostics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Simsen Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 5, 2026
GrantApr 23, 2024
GrantNov 9, 2022

Key People

Founding team and executive leadership

Pontus Rehn

Chief Executive Officer

Executive Team

Stefan F.

Chief Technology Officer

Executive Team

Simsen Diagnostics Investors

Notable investors and investment history

Simsen Diagnostics investors
InvestorRounds
Swedish Research Council for Sustainable Development (Formas)Grant
Vasa Angels IEarly Funding
VinnovaGrant
J.F.B InvestEarly Funding
SwelifeGrant
Nordic IgniteEarly Funding
Gobia EnterprisesEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 5, 2026

    $1.08M raised, led by Gobia Enterprises.

  • May 1, 2025

    Monthly visitors grew 733% MoM, from 192 to 1.6K.

Simsen Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Simsen Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Simsen Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMölndal
Employee Range9
Year Founded2020
Last FundingMay 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.